Atovaquone
NDC 42239-001, Atovaquone, suspension, from Abon Pharmaceuticals, LLC.
- Product NDC
- 42239-001
- Status
- Listed
- Labeler
- Abon Pharmaceuticals, LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214272
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42239-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATOVAQUONE750 mg/5mL
Pharmacologic classes
Antimalarial [EPC]; Antiprotozoal [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42239-001-08 | 42239000108 | 1 BOTTLE in 1 CARTON (42239-001-08) / 210 mL in 1 BOTTLE |
| 42239-001-66 | 42239000166 | 6 CUP, UNIT-DOSE in 1 TRAY (42239-001-66) / 5 mL in 1 CUP, UNIT-DOSE (42239-001-17) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2d3715ed-6ddc-4c10-9d2c-9c80cb1dfd08
Use it
Look up 42239-001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42239-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42239-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.